Introducing JCO Oncology Advances Editor-in-Chief

ASCO shared on LinkedIn:

“We and JCO Oncology Advances (JCO OA) are proud to introduce you to our Editor-in-Chief Pamela Kunz.

Under her leadership, JCO OA aims to bridge the gap between accessible scientific research and clinical care.

A distinguished medical oncologist and international expert in neuroendocrine tumors, Dr. Kunz currently leads the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center.

In her own words, Dr. Kunz is ‘committed to shaping JCO OA into the foremost oncology open-access journal.

By publishing a wide array of content, we aim to engage a diverse audience, encompassing academics, community practitioners, international colleagues, and patient partners. Our accessible online format empowers us to be innovative, agile, and impactful, extending our reach far beyond conventional boundaries.’

Visit JCO OA to learn more about the vision for JCO OA and read groundbreaking articles on breast and gastrointestinal cancers.”

Source: ASCO/LinkedIn

Pamela Kunz is an Associate Professor of Medicine in the Division of Oncology at Yale School of Medicine, Director of the Center for Gastrointestinal Cancers at Yale Cancer Center and Smilow Cancer Hospital. She was formerly the director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship.

Dr. Kunz is the President of the North American Neuroendocrine Tumor Society (NANETS) and Chair of the Neuroendocrine Tumor Taskforce of the NCI. In addition, she has emerged as a leading voice for promoting gender equity in the medical workforce and has been appointed as the Vice Chief for DEI for the Section of Medical Oncology at Yale.